Sign in or register to see full information and data.

Studies / CAVD 762

Overview

Study information

Network:CAVD
Grant Affiliation:McElrath: Durability of HIV-Specific Protective Ab Response
Strategy:Protein & peptide vaccines
Study Type:Pre-Clinical Non-NHP
Species:Rat
Stage:Assays complete
Study Start Date:2018-11-09
Study Made Public:2020-05-29

Title

Antibody responses to BG505 SOSIP.664 with multiple adjuvants in a repeat dose intramuscular injection toxicity study in rats

Description

CAVD 762 is a preclinical study to compare antibody responses to regimens using BG505 SOSIP.664 combined with multiple adjuvants in rats.

Products

Alum BG505 SOSIP.664 GLA-LSQ Saline 3M-052 CpG 1018

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.